Search Results
Panel Discussion with Dr. Pourhassan, Dr. Patterson, & Dr. Lalezari on treatment for COVID-19
Positive recommendations from DSMC for Leronlimab’s Phase 3 CD12 COVID-19 study & what this means
CytoDyn, Inc. (OTCQB: CYDY)
FOX Business Network Interview with CytoDyn’s CEO, Dr. Nader Pourhassan (April 7, 2020)
Proactive: Results of Recent Blood Samples for COVID-19 Patients (April 9, 2020)
Full interview with Dr. Jacob Lalezari
Dr. Jacob Lalezari discusses Leronlimab for COVID19 (KRON News April 23, 2020)
Biologic therapy for multidrug-resistant HIV offers new hope
C. Hart Merriam Award Presentation - Bruce Patterson
CytoDyn, Inc. (OTCQB: CYDY)
CytoDyn Investment Community Conference Call (August 12)
Presentation to NIH Colleagues: Leronlimab for COVID-19 (12/21)
